The Epoch Times
The Epoch Times
Focus

Merck & Co

US
US
|
Reuters

FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment

Jul 28, 2021
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment
Jul 28
|
FacebookXTruthGettrLinkedInTelegramEmail
US News
US News
|
Reuters

Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment

Dec 23, 2020
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment
Dec 23
|
FacebookXTruthGettrLinkedInTelegramEmail
US
US
|
Reuters

FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment

Jul 28, 2021
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment
Jul 28
|
FacebookXTruthGettrLinkedInTelegramEmail
US News
US News
|
Reuters

Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment

Dec 23, 2020
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment
Dec 23
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.